Opportunity timeline
In plain English
The National Institutes of Health is seeking information from qualified businesses that can provide full-service medicinal chemistry support for therapeutic development. Work may include project management, compound logistics, synthesis, computational chemistry, SAR analysis, and in vitro ADMET studies across exploratory, hit-to-lead, and lead-optimization stages, supporting 1–10 projects at once. Small businesses and businesses with qualifying socioeconomic statuses are encouraged to respond; this is market research, not a request for proposals. Responses are due by 1:00 p.m. Eastern on September 14, 2026, by email to the listed NIH contacts, using solicitation number 75N98026R00144SB in the subject line.
About this opportunity
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified business sources; (2) determine whether they are small businesses (e.g., 8(a), Veteran-owned small businesses, service-disabled Veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, and women-owned small businesses); (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition; and (4) the availability of domestically manufactured and commercial services. Your…
Time remaining
Closes Sep 14, 2026
Related Opportunities

Illumina DRAGEN Tier 3 Throughput License and v4 Server

Emergent Drug Panel-Version 2 (EDP-V2) Kit

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Health Advisory Committees Research and Support

N66001-26-R-0030 - Academic Research MAC
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-8523CC

